{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:59:53Z","timestamp":1792007993260,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Transmasculine individuals require patient-centered and shared decision-making approaches to address menstrual suppression and contraceptive needs. Gender-affirming testosterone therapy may be utilized by individuals to achieve menstrual suppression but is not a reliable form of contraception. While menstrual suppression and contraception are not mutually exclusive, this article provides a framework to help determine patient goals and points of consideration when selecting treatments. A table (Table 1) and decision tree (Fig. 1) of options are provided to assist clinicians in addressing a patient\u2019s unique reproductive needs with a focus on individualized and informed care.<\/jats:p>","DOI":"10.1097\/grf.0000000000000953","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:00:14Z","timestamp":1752667214000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Contraception and Menstrual Suppression for Transmasculine Patients"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-1091","authenticated-orcid":false,"given":"Daniel S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"R2-20250827","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000004294","article-title":"Health care for transgender and gender diverse individuals: ACOG committee opinion, number 823","volume":"137","year":"2021","journal-title":"Obstetr Gynecol"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"key":"R4-20250827","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.contraception.2016.09.005","article-title":"Contraceptive use and pregnancy intentions among transgender men presenting to a clinic for sex workers and their families in San Francisco","volume":"95","author":"Cipres","year":"2017","journal-title":"Contraception"},{"key":"R5-20250827","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1097\/01.AOG.0000533319.47797.7e","article-title":"Contraception knowledge in transgender individuals: are we doing enough? [9F]","volume":"131","author":"Abern","year":"2018","journal-title":"Obstetr Gynecol"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"issue":"suppl1","key":"R7-20250827","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"key":"R8-20250827","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000003308","article-title":"Approaches to vaginal bleeding and contraceptive counseling in transgender and gender nonbinary patients","volume":"134","author":"Schwartz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajog.2019.07.043","article-title":"Contraception across the transmasculine spectrum","volume":"222","author":"Krempasky","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/26895269.2020.1719951","article-title":"Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: a prospective cohort study (ENIGI)","volume":"21","author":"Defreyne","year":"2020","journal-title":"Int J Transgend Health"},{"key":"R12-20250827","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/trgh.2017.0021","article-title":"Induction and maintenance of amenorrhea in transmasculine and nonbinary adolescents","volume":"2","author":"Carswell","year":"2017","journal-title":"Transgend Health"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/jc.2017-00359","article-title":"Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients","volume":"102","author":"Spratt","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"R14-20250827","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.contraception.2020.04.001","article-title":"Society of Family Planning clinical recommendations: contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth","volume":"102","author":"Bonnington","year":"2020","journal-title":"Contraception"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpag.2021.04.004","article-title":"Breakthrough bleeding in transgender and gender diverse adolescents and young adults on long-term testosterone","volume":"34","author":"Grimstad","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R16-20250827","author":"Obedin-Maliver"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/AOG.0000000000005123","article-title":"Outcomes of menstrual management use in transgender and gender-diverse adolescents","volume":"141","author":"Schwartz","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R18-20250827","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-0528.2007.01427.x","article-title":"Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation","volume":"115","author":"Kleijn","year":"2008","journal-title":"BJOG"},{"key":"R19-20250827","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/1471-0528.12213","article-title":"Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for heavy menstrual bleeding","volume":"120","author":"Herman","year":"2013","journal-title":"BJOG"},{"key":"R20-20250827","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/trgh.2022.0207","article-title":"Uterine and ovarian histopathology after testosterone for gender affirmation: a systematic review","volume":"9","author":"Toland","year":"2024","journal-title":"Transgend Health"},{"key":"R21-20250827","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AOG.0000000000004899","article-title":"General approaches to medical management of menstrual suppression: ACOG clinical consensus No. 3","volume":"140","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R23-20250827","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpag.2022.10.007","article-title":"Menstrual suppression in adolescent and young adult transgender males","volume":"36","author":"Alaniz","year":"2023","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R24-20250827","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13625187.2019.1709963","article-title":"Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese women adolescent and adult women","volume":"25","author":"Sims","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R26-20250827"},{"key":"R27-20250827","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/dew222","article-title":"Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant","volume":"31","author":"Ali","year":"2016","journal-title":"Hum Reprod"},{"key":"R28-20250827","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpag.2012.08.007","article-title":"Menstrual suppression in the adolescent","volume":"26","author":"Kantartzis","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R29-20250827","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20250827","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R31-20250827","doi-asserted-by":"crossref","first-page":"26334941231158251","DOI":"10.1177\/26334941231158251","article-title":"Reversible interventions for menstrual management in adolescents and young adults with gender incongruence","volume":"17","author":"Roden","year":"2023","journal-title":"Ther Adv Reprod Health"},{"key":"R32-20250827","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2018.12.021","article-title":"Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series","volume":"220","author":"Grimstad","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R34-20250827","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","article-title":"Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","year":"2019","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:00:32Z","timestamp":1756292432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000953","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}